BMP4-driven morphogenetic reprogramming sustains EGFR-TKI resistance via SOX2 suppression and EMT activation. - Chen A; Xie DJ; Jhu YW; Lin YJ; Wu DY; Yan SL; Chou YT; Ko JC (Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2026)